Go to the profile of Affimed

Affimed

Executive, Affimed

About Affimed

ffimed (Nasdaq: AFMD) is a clinical-stage immuno-oncology company committed to giving patients back their innate ability to fight cancer. Affimed’s fit-for-purpose ROCK® platform allows innate cell engagers to be designed for specific patient populations. The Company is developing single and combination therapies to treat hematologic and solid tumors. For more information, please visit www.affimed.com.

Therapeutic Areas

Oncology

Technologies

Antibodies

Company Type

Biotechnology – Therapeutics

State of Ownership

Public

Sponsorship Group

Networker